Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H19N3S |
| Molecular Weight | 261.386 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCN(CC1=CSC=C1)C2=CC=CC=N2
InChI
InChIKey=RCGYDFVCAAKKNG-UHFFFAOYSA-N
InChI=1S/C14H19N3S/c1-16(2)8-9-17(11-13-6-10-18-12-13)14-5-3-4-7-15-14/h3-7,10,12H,8-9,11H2,1-2H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18963353
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18963353
There is not much available information about thenyldiamine, is known, that it is used as antihistamine and for the treatment of asthma and bronchitis.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Direct analysis of microbial extracts containing metabolites of ethylenediamine-type antihistamines via high-performance liquid chromatography-thermospray mass spectrometry. | 1990-02-15 |
|
| Mutagenicity of amine drugs and their products of nitrosation. | 1984-02 |
|
| Trace determination of the antihistamines tripelennamine hydrochloride, thenyldiamine hydrochloride, and chlorothen citrate in admixture in animal feed, human urine, and wastewater by high-pressure liquid chromatography and use of a fluorescence detector. | 1983-04 |
|
| Isoetharine methanesulfonate with phenylephrine hydrochloride and thenyldiamine (Bronkometer) in hypertensive and sympathomimetic amine-sensitive asthmatic patients. | 1967-02 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
E4U52363JE
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
91-79-2
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
C005822
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107485
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
202-098-2
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
m10701
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | Merck Index | ||
|
THENYLDIAMINE
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
7066
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
5190
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
318
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
38025
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB10962MIG
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
C84200
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
100000082394
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY | |||
|
DTXSID0021335
Created by
admin on Mon Mar 31 18:00:28 GMT 2025 , Edited by admin on Mon Mar 31 18:00:28 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)